KIT and gastrointestinal stromal tumor: Previous reports have shown that the primary mutation of GIST-related genes in primary tumors is a KIT mutation in 75–85% of all patients with GISTs, PDGFRA mutation in approximately 10%, and wild-type in the remaining 10%, wherein no mutation is observed in either genes [18–20].